Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
08 2019
Historique:
received: 29 01 2019
revised: 30 04 2019
accepted: 05 05 2019
pubmed: 10 5 2019
medline: 21 4 2020
entrez: 10 5 2019
Statut: ppublish

Résumé

Here we describe a 10-year-old girl with combined immunodeficiency presenting as recurring chest infections, lung disease and herpetic skin infections. The patient experienced two hematopoietic stem cell transplantations and despite full chimerism, she developed bone marrow aplasia due to adenovirus infection and died at post-transplant day 86. Immunologic investigation revealed low numbers of TRECs/KRECs, a severe reduction of memory B cells, absence of isohemagglutinins, and low IgG levels. Whole exome sequencing (WES) identified a novel heterozygous mutation in RAC2(c.275A > C, p.N92 T). Flow cytometric investigation of neutrophil migration demonstrated an absence of chemotaxis to fMLP. Cell lines transfected with RAC2 [N92 T] displayed characteristics of active GTP-bound RAC2 including enhanced NADPH oxidase-derived superoxide production both at rest and in response to PMA. Our findings broaden the clinical picture of RAC2 dysfunction, showing that some individuals can present with a combined immunodeficiency later in childhood rather than a congenital neutrophil disease.

Identifiants

pubmed: 31071452
pii: S1521-6616(19)30041-5
doi: 10.1016/j.clim.2019.05.003
pii:
doi:

Substances chimiques

Immunoglobulins, Intravenous 0
Immunologic Factors 0
rac GTP-Binding Proteins EC 3.6.5.2

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-5

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Svetlana O Sharapova (SO)

Research department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk region, Belarus. Electronic address: sharapovasv@gmail.com.

Emma Haapaniemi (E)

Department of Hematology and Regenerative Medicine, Karolinska Institutet, Huddinge, Sweden; Biomedicum Stem Cell Center, University of Helsinki, Finland; Center for Molecular Medicine Norway, University of Oslo, Norway.

Inga S Sakovich (IS)

Research department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk region, Belarus.

Larysa V Kostyuchenko (LV)

West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.

Agnes Donkó (A)

Molecular Defenses Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, USA.

Alina Dulau-Florea (A)

Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, USA.

Oksana Malko (O)

Rivne Regional Children's Hospital, Rivne, Ukraine.

Anastasia V Bondarenko (AV)

Department of Pediatric Infectious Diseases and Pediatric Immunology, P.L. Shupyk National Medical Academy for Postgraduate Education, Kiev, Ukraine.

Maria V Stegantseva (MV)

Research department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk region, Belarus.

Thomas L Leto (TL)

Molecular Defenses Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, USA.

Vedat Uygun (V)

Pediatric Bone Marrow Transplantation Unit, Medical Park Antalya Hospital, Antalya, Turkey.

Gulsun Tezcan Karasu (GT)

Pediatric Bone Marrow Transplantation Unit, Medical Park Antalya Hospital, Antalya, Turkey.

Steven M Holland (SM)

Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, USA.

Amy P Hsu (AP)

Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, USA.

Olga V Aleinikova (OV)

Research department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk region, Belarus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH